Coherus Oncology, Inc. (CHRS)

NASDAQ: CHRS · Real-Time Price · USD

1.270

-0.020 (-1.55%)

At close: Sep 15, 2025, 4:00 PM EDT

1.260

-0.010 (-0.79%)

After-hours: Sep 15, 2025, 6:48 PM EDT

Revenue by Product

Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2013 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2013 - 2019
Human Pharmaceutical Products	266.96M	Log In	Log In	Log In	Log In	Upgrade
Human Pharmaceutical Products Growth	3.78%	Log In	Log In	Log In	Log In	Upgrade

Revenue by Geography

Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2013 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2013 - 2019
United States	266.96M	Log In	Log In	Log In	Log In	Upgrade
United States Growth	3.78%	Log In	Log In	Log In	Log In	Upgrade